Phibro Animal Health Corporation (NASDAQ:PAHC) COO Larry Lee Miller sold 21,439 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $36.43, for a total value of $781,022.77. Following the completion of the transaction, the chief operating officer now owns 15,891 shares of the company’s stock, valued at approximately $578,909.13. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Larry Lee Miller also recently made the following trade(s):

  • On Wednesday, September 13th, Larry Lee Miller sold 15,891 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $36.46, for a total value of $579,385.86.
  • On Tuesday, September 12th, Larry Lee Miller sold 46,102 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $36.33, for a total value of $1,674,885.66.
  • On Thursday, September 7th, Larry Lee Miller sold 32,459 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $35.59, for a total value of $1,155,215.81.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) traded down 0.97% during trading on Friday, hitting $35.75. The stock had a trading volume of 267,714 shares. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of 22.20 and a beta of 1.36. The stock has a 50-day moving average of $37.99 and a 200 day moving average of $33.77. Phibro Animal Health Corporation has a 12-month low of $24.83 and a 12-month high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 30th. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The business had revenue of $194.84 million during the quarter, compared to analyst estimates of $192.47 million. During the same quarter last year, the firm earned $0.32 earnings per share. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. On average, analysts predict that Phibro Animal Health Corporation will post $1.57 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be paid a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is currently 24.69%.

COPYRIGHT VIOLATION WARNING: “Phibro Animal Health Corporation (PAHC) COO Sells $781,022.77 in Stock” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/15/phibro-animal-health-corporation-pahc-coo-sells-781022-77-in-stock.html.

Several brokerages have recently issued reports on PAHC. BidaskClub upgraded Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Credit Suisse Group lifted their price objective on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research note on Thursday, August 31st. Piper Jaffray Companies reiterated a “buy” rating and issued a $41.00 price objective (down previously from $42.00) on shares of Phibro Animal Health Corporation in a research note on Thursday, August 31st. Finally, Bank of America Corporation reiterated an “underperform” rating and issued a $33.00 price objective on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $34.00.

Several hedge funds have recently bought and sold shares of the company. Alps Advisors Inc. grew its stake in shares of Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after buying an additional 46 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock valued at $211,000 after buying an additional 100 shares in the last quarter. Arizona State Retirement System boosted its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after purchasing an additional 100 shares during the last quarter. Nationwide Fund Advisors boosted its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock valued at $403,000 after purchasing an additional 110 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan boosted its holdings in Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after purchasing an additional 150 shares during the last quarter. Institutional investors and hedge funds own 48.35% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.